Supreme Court Sides with Bayer in Roundup Case, Limiting Thousands of Cancer Lawsuits
June 25, 2026 According to reporting from ABC News, the U.S. Supreme Court has ruled in favor of Bayer in a closely watched Roundup case, a decision expected to significantly limit thousands of failure-to-warn lawsuits alleging that the herbicide causes cancer.
The ruling centers on whether Bayer, which acquired Monsanto and the Roundup brand in 2018, can be held liable under state laws for not including cancer warnings on Roundup labels when federal regulators have approved the product’s labeling. The Court determined that federal pesticide regulations preempt such state-law claims, finding that Bayer cannot be sued in state courts for failing to provide warnings that conflict with federally approved labeling requirements.
The case originated with Missouri resident John Durnell, who developed non-Hodgkin’s lymphoma after more than two decades of applying Roundup in his St. Louis neighborhood. A jury previously awarded Durnell $1.25 million after concluding the company failed to adequately warn users of potential cancer risks. His case was one of approximately 200,000 claims filed against Bayer related to Roundup and glyphosate exposure.
The decision marks a significant legal victory for Bayer, which has spent years defending itself against litigation while setting aside an estimated $16 billion to settle claims. Earlier this year, the company proposed an additional $7.25 billion settlement intended to resolve many remaining cases.
The ruling comes amid continued scientific and regulatory debate surrounding glyphosate, Roundup’s active ingredient. In 2015, the World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic.” However, the U.S. Environmental Protection Agency has consistently maintained that glyphosate is not likely to cause cancer in humans when used according to label directions.
The case has broader implications for U.S. agriculture. Bayer has previously warned that continued litigation could force it to reconsider the future availability of glyphosate-based products in the U.S. agricultural market. Agricultural organizations have argued that losing access to glyphosate would have significant impacts on crop production, weed management, and food supply chains.
The decision also arrives amid ongoing policy debates within the Trump administration and the Make America Healthy Again (MAHA) movement regarding pesticide regulation, agricultural productivity, and food security.
CropLife has reached out to national and state agricultural trade associations, as well as agrochemical manufacturers, for comment. Look for additional coverage and industry reaction as more information becomes available.
Subscribe Today For
